全文获取类型
收费全文 | 94222篇 |
免费 | 6215篇 |
国内免费 | 1846篇 |
专业分类
耳鼻咽喉 | 1144篇 |
儿科学 | 2291篇 |
妇产科学 | 1032篇 |
基础医学 | 9079篇 |
口腔科学 | 3036篇 |
临床医学 | 7499篇 |
内科学 | 12286篇 |
皮肤病学 | 1087篇 |
神经病学 | 15197篇 |
特种医学 | 3377篇 |
外国民族医学 | 12篇 |
外科学 | 18051篇 |
综合类 | 9320篇 |
现状与发展 | 4篇 |
一般理论 | 6篇 |
预防医学 | 4700篇 |
眼科学 | 1489篇 |
药学 | 6678篇 |
78篇 | |
中国医学 | 3451篇 |
肿瘤学 | 2466篇 |
出版年
2024年 | 180篇 |
2023年 | 1720篇 |
2022年 | 2622篇 |
2021年 | 4881篇 |
2020年 | 4495篇 |
2019年 | 5024篇 |
2018年 | 4682篇 |
2017年 | 4038篇 |
2016年 | 3473篇 |
2015年 | 3318篇 |
2014年 | 7055篇 |
2013年 | 8417篇 |
2012年 | 5983篇 |
2011年 | 6001篇 |
2010年 | 4699篇 |
2009年 | 4385篇 |
2008年 | 4002篇 |
2007年 | 3525篇 |
2006年 | 2918篇 |
2005年 | 2573篇 |
2004年 | 2393篇 |
2003年 | 1927篇 |
2002年 | 1483篇 |
2001年 | 1248篇 |
2000年 | 1089篇 |
1999年 | 944篇 |
1998年 | 779篇 |
1997年 | 787篇 |
1996年 | 540篇 |
1995年 | 423篇 |
1994年 | 389篇 |
1993年 | 347篇 |
1992年 | 247篇 |
1991年 | 232篇 |
1990年 | 187篇 |
1989年 | 153篇 |
1988年 | 133篇 |
1985年 | 633篇 |
1984年 | 661篇 |
1983年 | 442篇 |
1982年 | 529篇 |
1981年 | 459篇 |
1980年 | 359篇 |
1979年 | 348篇 |
1978年 | 291篇 |
1977年 | 223篇 |
1976年 | 220篇 |
1975年 | 247篇 |
1974年 | 171篇 |
1973年 | 177篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
31.
Thomas Ruffing Tilmann Rückauer Frederic Bludau Alexander Hofmann Markus Muhm Arnold J Suda 《Injury》2019,50(2):607-612
Introduction
Compression fractures of the cuboid bone in children and adolescents are rare. Fracture morphology, associated lesions, treatment options and long-term outcomes of this very rare injury are published in a few case reports. This study with review of the literature aims to support the understanding of fracture pattern and optimize pathways of decision making.Material and Methods
A retrospective two-center study was performed in a patient cohort treated between 2001 and 2016. All patients aged less than 18 years who sustained a cuboid fracture were included. Age, gender, mechanism of injury, fracture morphology, amount of displacement, associated injuries, and therapy were analyzed. In the follow-up (FU), the AOFAS Midfoot Scale was investigated.Results
Fractures of the cuboid bone were diagnosed in 7 boys and 9 girls. The mean age of the patients was 10 years (range: 2.2–16.1 years). According to the classification of Fenton we detected 11 (69%) type 2, 2 (12%) type 3 and 3 (19%) type 5b fractures. Other fracture types according to Fenton were not observed. All children under 10 years sustained a type 2 fracture. Open reduction and internal fixation was performed in 5 (31%) patients. Bone grafting was not necessary. FU was performed in 14/16 patients on average after 9 years (mean; range: 1.4–16.2 years). The mean AOFAS Midfoot Scale at FU for extra-articular type 2 fractures was 100 points, whereas in intra-articular fractures (Type 3) and fractures associated with mid-tarsal disruption (type 5b) worse results were found (95 and 66 points, accordingly).Conclusion
This rare injury shows inhomogenous morphologies and offers different treatment approaches. Extra-articular Fenton type 2 lesions are the most common type of cuboid fracture in children (69%). A potential loss of length of the lateral column must be considered. In contrast to adults, type 1, 4, and 5a fractures were not found in our cohort of children and adolescents. Lower scores of the AOFAS Midfoot Scale were found with either intra-articular involvement or associated midfoot lesions. 相似文献32.
骨质疏松症是常见的骨骼疾病,绝经后女性为骨质疏松症的高危人群。骨折风险评价工具(fracture risk assessment tool,FRAX?)是一款研究、应用广泛的骨折风险评估工具。近年来研究表明,虽然FRAX?尚不完美,但对女性人群的骨折具有合理的预测能力,结合其他骨折危险因素对该工具进行调整、改进的研究也多见报道。设立符合本国国情的FRAX?阈值有助于医生更好地使用该工具和进行临床决策。美国设立了固定的FRAX?阈值,英国则是按年龄分层的阈值。国内对FRAX?的研究尚处于初级阶段,暂无特异的干预阈值,这在一定程度上阻碍了该工具在我国的推广使用。笔者回顾了国内外FRAX?对女性骨质疏松性骨折的预测能力、骨量异常的诊断能力、在合并其他疾病的女性人群中的应用和干预阈值的研究等最新成果,为临床医生了解FRAX?的研究进展、探索针对我国人群干预阈值奠定基础。 相似文献
33.
34.
AimsThe effect of Origanum majorana tea consumption on motor and non-motor symptoms was investigated in patients with idiopathic Parkinson's disease, measured by validated tools.MethodsSixty patients with idiopathic Parkinson's disease and under conventional medication were enrolled voluntarily in the study. All participants were randomized on double-blind to placebo or Origanum majorana. Clinical assessment with validated tools (UPDRSIII, NMSS, and BDI) was done before Origanum majorana or placebo consumption (Day 0) and at the end of the experiment (Day 30).ResultsThe treatment groups were similar at baseline on demographic and clinical variables. During the course of study, nine participants withdrew for reasons of noncompliance and inability to follow-up. Fifty-one participants completed the study. Upon completion of 30 days of treatment, Origanum majorana tea consumption did not decrease the UPDRSIII score ([UPDRSIII] D0 = 18.76 ± 8.58, D30 = 16.52 ± 7.96, p = 0.069) at the p value was 0.07. However, a statistically significant improvement was noted in NMSS and BDI scores (p < 0.0001 and p < 0.0001, respectively). Assessment of the UPDRSIII, NMSS and BDI scores of the patients did not reflect any improvement with placebo. No side effect was detected during the study.ConclusionThese findings show improvement of depressive and non-motor signs in patients with Parkinson's disease in the group that consumed Origanum majorana tea in combination with conventional therapy. Improvement of motor signs may need an extended treatment period. However, more research with a large number of participants and lasting longer than 1 month is needed to argue these findings. 相似文献
35.
36.
37.
《Clinical neurophysiology》2020,131(7):1444-1452
ObjectiveTo investigate cognitive functions in non-demented patients with early-onset Parkinson's disease (PD), and to compare PARK2 gene mutation carriers and non-carriers by means of event-related brain potentials (ERPs).MethodsThe participants comprised patients with early-onset PD (EOPD) and healthy controls (HC). Patients with EOPD were divided into two groups as carriers of known pathogenic variants of PARK2 gene (EOPD-PC) and non-carriers of genes involved in familial PD (EOPD-NC). ERP data were collected during auditory oddball and visual continuous performance test (CPT).ResultsBoth EOPD groups (EOPD-PC and EOPD-NC) displayed reduced and delayed P3 in response to oddball target and CPT NoGo. CPT Go P3 was reduced in EOPD-NC but not in EOPD-PC. Oddball target N1 was reduced and P2 was enhanced in both EOPD-PC and EOPD-NC. In both cognitive tasks, RTs were prolonged and accuracy was lower in EOPD-PC and EOPD-NC.ConclusionsWe found several EOPD-related neurophysiologic changes, implying impairments in cognitive functions. Pairwise comparisons between EOPD-PC and EOPD-NC revealed no significant ERP marker.SignificanceIn this study, the confounding effect of normative aging was somewhat excluded compared with many previous studies. In contrast with the many oddball studies in non-demented PD, we clearly observed reduced and prolonged P3 in early-onset PD. Our NoGo P3 findings also contribute to the limited ERP research concerning response inhibition. 相似文献
38.
39.
40.